We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EU
2326
enCore Energy
EU
$206M
| $220K | 0.01% |
88,545
-140,770
| -61% | -$402K |
|
2327
Stem
STEM
$44.3M
| $219K | 0.01% |
14,579
-8,139
| -36% | -$156K |
|
|
BZUN
2328
Baozun
BZUN
$179M
| $219K | 0.01% |
+82,363
| New | +$259K |
|
2329
TScan Therapeutics
TCRX
$48.5M
| $219K | 0.01% |
219,001
+201,375
| +1,142% | +$291K |
|
2330
Kyverna Therapeutics
KYTX
$430M
| $219K | 0.01% |
23,282
-25,825
| -53% | -$192K |
|
2331
Simon Property Group
SPG
$76.4B
| $219K | 0.01% |
+1,182
| New | +$215K |
|
2332
Aldeyra Therapeutics
ALDX
$97.1M
| $219K | 0.01% |
42,227
+7,761
| +23% | +$39.9K |
|
2333
Nurix Therapeutics
NRIX
$2.45B
| $219K | 0.01% |
11,520
-11,282
| -49% | -$162K |
|
|
GLDD
2334
DELISTED
Great Lakes Dredge & Dock
GLDD
| $219K | 0.01% |
16,654
+5,627
| +51% | +$69.3K |
|
2335
Lattice Semiconductor
LSCC
$16B
| $218K | 0.01% |
+2,966
| New | +$211K |
|
2336
Shutterstock
SSTK
$209M
| $218K | 0.01% |
11,416
-991
| -8% | -$21.2K |
|
|
FPF
2337
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.07B
| $218K | 0.01% |
+11,692
| New | +$219K |
|
2338
United Fire Group
UFCS
$1.35B
| $218K | 0.01% |
+5,989
| New | +$205K |
|
2339
Greenwich LifeSciences
GLSI
$188M
| $217K | 0.01% |
+10,325
| New | +$109K |
|
2340
CRH
CRH
$66.6B
| $217K | 0.01% |
+1,736
| New | +$207K |
|
2341
Definitive Healthcare
DH
$77M
| $216K | 0.01% |
75,306
+27,495
| +58% | +$76.2K |
|
2342
Galectin Therapeutics
GALT
$230M
| $216K | 0.01% |
+51,936
| New | +$273K |
|
2343
enGene Therapeutics
ENGN
$120M
| $216K | 0.01% |
+23,922
| New | +$192K |
|
2344
American Well
AMWL
$180M
| $215K | 0.01% |
+43,785
| New | +$211K |
|
2345
M&T Bank
MTB
$36.3B
| $215K | 0.01% |
1,067
-130
| -11% | -$24.8K |
|
2346
Aligos Therapeutics
ALGS
$26.3M
| $215K | 0.01% |
+23,053
| New | +$217K |
|
|
SFD
2347
Smithfield Foods
SFD
$10.8B
| $215K | 0.01% |
9,620
-38,119
| -80% | -$839K |
|
2348
Franklin Covey
FC
$239M
| $215K | 0.01% |
12,800
-125
| -1% | -$2.09K |
|
2349
Afya
AFYA
$1.35B
| $215K | 0.01% |
+13,920
| New | +$205K |
|
|
MCW
2350
DELISTED
Mister Car Wash
MCW
| $214K | 0.01% |
38,556
-27,965
| -42% | -$147K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.